Sermonix Pharmaceuticals @SermonixPharma
Currently studying investigational oral lasofoxifene for the treatment of locally advanced or metastatic ER+/HER2- breast cancer harboring an ESR1 mutation(s). sermonixpharma.com Joined June 2022-
Tweets91
-
Followers67
-
Following10
-
Likes9
Trends for United States
3.431 posts
16,3 B posts
18,9 B posts
18 B posts
20,4 B posts
6.501 posts
4.630 posts
19,4 B posts
1.348 posts
58,3 B posts
2.320 posts
317 B posts
1.075 posts
33,5 B posts
9.676 posts
2.503 posts
1.804 posts
25,7 B posts